Manejo óptimo de la glucemia en el paciente neurocrítico

Translated title of the contribution: Optimal management of blood glucose levels in neurocritical patients

Daniel A. Godoy, Alejandro Rabinstein, Walter Videtta, Francisco Murillo-Cabezas

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


To review the most significant studies on the pathophysiology of hypoglycaemia and hyperglycaemia in neurocritical patients and the therapeutic interventions used to control them. Development. Available evidence shows that hypoglycaemia and hyperglycaemia increase brain injury and aggravate the prognosis, but it fails to establish the most suitable levels of blood glucose. Intensive treatment with insulin, compared with more moderate regimes, has not improved the prognosis and leads to further episodes of hypoglycaemia. Conclusions. Hypoglycaemia must always be avoided. Intensive treatment to control hyperglycaemia does not offer any kind of advantages and increases the likelihood of hypoglycaemia; it therefore cannot be recommended in neurocritical patients. No evidence is available showing the optimal level of blood glucose or the most suitable insulin regime, although its use is generally indicated when blood glucose levels are higher than 180-200 mg/dL. The value of the pharmacological control of blood glucose levels to improve the prognosis remains uncertain.

Translated title of the contributionOptimal management of blood glucose levels in neurocritical patients
Original languageSpanish
Pages (from-to)745-756
Number of pages12
JournalRevista de Neurologia
Issue number12
StatePublished - Dec 16 2010


  • Glycemia management in neurocritical patients
  • Hyperglycemia

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Optimal management of blood glucose levels in neurocritical patients'. Together they form a unique fingerprint.

Cite this